Ingram Micro Holdingの空売り状況は、投資家がIngram Micro Holdingの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Ingram Micro Holding (NYSE:INGM) 株価情報, 空売り情報

INGRAM MICRO HOLDING CORP

Ingram Micro Holding

Ingram Micro Holding Corp is a technology company for the global information technology ecosystem. The company plays a vital role in the IT sales channel, bringing products and services from technology manufacturers and cloud providers to business-to-business technology experts. The company also provide a broad range of technology services, including financing, specialized marketing, and lifecycle management, as well as technical pre- and post-sales professional support.

Ingram Micro Holding Corporation Common Stock

Ingram Micro Holding Corp

BioRestorative Therapies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRTX#NASDAQ">BRTX</a>) reported quarterly losses of $(0.64) per share which missed the analyst consensus estimate of $(0.33) by 93.94 percent. This is a 93.94 percent decrease over losses of $(0.33) per share from the same period last year. The company reported quarterly sales of $25.00 thousand which missed the analyst consensus estimate of $380.00 thousand by 93.42 percent. This is a 28.57 percent decrease over sales of $35.00 thousand the same period last year.

Earnings

Earnings Misses

News

BRTX

BioRestorative Therapies Q1 EPS $(0.64) Misses $(0.33) Estimate, Sales $25.00K Miss $380.00K Estimate

Aeva Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AEVA#NYSE">AEVA</a>) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.48) by 6.25 percent. This is a 19.64 percent increase over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $3.37 million which beat the analyst consensus estimate of $2.33 million by 44.55 percent. This is a 59.85 percent increase over sales of $2.11 million the same period last year.

Earnings Beats

AEVA

Aeva Technologies Q1 Adj. EPS $(0.45) Beats $(0.48) Estimate, Sales $3.37M Beat $2.33M Estimate

Cisco Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSCO#NASDAQ">CSCO</a>) reported quarterly earnings of $0.96 per share which beat the analyst consensus estimate of $0.92 by 4.35 percent. This is a 9.09 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $14.15 billion which beat the analyst consensus estimate of $14.08 billion by 0.49 percent. This is a 11.39 percent increase over sales of $12.70 billion the same period last year.

CSCO

Cisco Systems Q3 Adj. EPS $0.96 Beats $0.92 Estimate, Sales $14.15B Beat $14.08B Estimate

Codexis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDXS#NASDAQ">CDXS</a>) reported quarterly losses of $(0.25) per share which missed the analyst consensus estimate of $(0.23) by 8.7 percent. This is a 56.25 percent decrease over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $7.54 million which missed the analyst consensus estimate of $9.66 million by 21.93 percent. This is a 55.82 percent decrease over sales of $17.07 million the same period last year.

CDXS

Codexis Q1 EPS $(0.25) Misses $(0.23) Estimate, Sales $7.54M Miss $9.66M Estimate

CRWV

CoreWeave Q1 GAAP EPS $(1.49), Sales $981.63M Beat $859.77M Estimate

ICCC

ImmuCell Q1 EPS $0.16 Up From $(0.06) YoY, Sales $8.07M Up From $7.26M YoY

Rekor Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REKR#NASDAQ">REKR</a>) reported quarterly losses of $(0.10) per share which missed the analyst consensus estimate of $(0.07) by 42.86 percent. This is a 58.33 percent increase over losses of $(0.24) per share from the same period last year. The company reported quarterly sales of $9.20 million which missed the analyst consensus estimate of $10.90 million by 15.65 percent. This is a 5.93 percent decrease over sales of $9.78 million the same period last year.

REKR

Rekor Systems Q1 EPS $(0.10) Misses $(0.07) Estimate, Sales $9.20M Miss $10.90M Estimate

CV Sciences (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CVSI#OTC">CVSI</a>) reported $3.61 million in sales this quarter. This is a 9.90 percent decrease over sales of $4.00 million the same period last year.

CVSI

CV Sciences Q1 Sales $3.61M Down From $4.00M YoY

Karooooo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KARO#NASDAQ">KARO</a>) reported quarterly earnings of $0.51 per share which beat the analyst consensus estimate of $0.37 by 37.84 percent. This is a 41.67 percent increase over earnings of $0.36 per share from the same period last year. The company reported quarterly sales of $65.56 million which beat the analyst consensus estimate of $62.90 million by 4.23 percent. This is a 13.21 percent increase over sales of $57.91 million the same period last year.

KARO

Karooooo Q4 Adj. EPS $0.51 Beats $0.37 Estimate, Sales $65.56M Beat $62.90M Estimate

Artivion, Inc. (NYSE:<a href="https://www.benzinga.com/stock/AORT#NYSE">AORT</a>),&nbsp;a leading cardiac and vascular surgery company focused on aortic disease, today announced that it entered into separate, privately negotiated exchange agreements with certain holders of its 4.250% Convertible Senior Notes due 2025 (the "Existing Convertible Notes"). Under the exchange agreements, the company will, subject to customary closing conditions, repurchase approximately $95 million principal amount of Existing Convertible Notes in exchange for a number of shares of the company's common stock to be determined based on the trading price of the common stock over a four trading day averaging period beginning on May 15, 2025 (the "Shares"). Although the number of Shares to be issued is subject to final determination, at yesterday's closing common stock price of $28.91 per share, the transaction would have resulted in the issuance of approximately 4.1 million Shares in total. In addition, pursuant to the exchange agreements,&nbsp;the company&nbsp;will pay cash to the holders for accrued and unpaid interest. These exchange transactions are expected to close on or about May 28, 2025, subject to the satisfaction of customary closing conditions.&nbsp;

AORT

Artivion Enters Into Separate, Privately Negotiated Exchange Agreements With Certain Holders Of 4.250% Convertible Senior Notes Due 2025

eGain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGAN#NASDAQ">EGAN</a>) raises FY2025 Adj EPS guidance from $0.14-$0.16 to $0.18-$0.20 vs $0.21 analyst estimate. Lowers FY2025 sales outlook from $88.50 million-$90.00 million to $88.00 million-$88.50 million vs $88.87 million estimate.

Guidance

EGAN

eGain Raises FY2025 Adj EPS Guidance from $0.14-$0.16 to $0.18-$0.20 vs $0.21 Est; Lowers FY2025 Sales Guidance from $88.50M-$90.00M to $88.00M-$88.50M vs $88.87M Est

New Fortress Energy Q1 Adj. EPS $(0.73) May Not Compare To $(0.06) Estimate, Sales $609.50M Miss $620.51M Estimate

The May update for the Perfect Stock Portfolio at Benzinga Edge begins with an acknowledgment of Benjamin Graham&#8217;s profound influence on modern securities markets.
From Graham&#8217;s Columbia University classroom emerged some of the greatest investment minds of the past century and I&#8217;d argue there aren&#8217;t many people who&#8217;ve had a bigger impact on how we invest today.
His notable students included Warren Buffett; Walter Schloss, who delivered approximately 20% returns before fees for 47 consecutive years (and whom Buffett once wrote a lovely letter of introduction for when closing one of his partnerships); Irving Kahn, founder of the still-thriving Kahn Brothers; and Bill Ruane of Sequoia Funds.
These figures not only applied Graham&#8217;s principles but propagated them throughout the investment world, creating a multi-generational impact.
Graham&#8217;s influence extends beyond traditional value circles to unexpected areas, with even venture capitalist William Obendorf acknowledging Graham&#8217;s impact on his high-tech and growth investment approach.
In addition to teaching, Graham authored &#8220;Security Analysis&#8221; and &#8220;The Intelligent Investor&#8221; with the latter breaking down his principles for the average investor and becoming the definitive text on value investing, despite being, as those of us in the industry know all too well, &#8220;one of the most frequently purchased and least frequently read books in all of finance.&#8221;
Graham developed two distinct formulas for investment success. The first, his net current asset formula, remains effective but represents a more aggressive approach that we&#8217;ll dive into another time.
The second, his defensive investor formula focusing on undervalued stocks with low debt, sufficient liquidity, profitability, and dividend payments forms the foundation of the Perfect Stock Portfolio&#8217;s strategy.
Graham&#8217;s influence created a cascade of investment excellence: from Buffett to Munger to Guerin to Pabrai, and from Schloss to his nephew Paul Isaacs of Arbiter Capital.
There&#8217;s just a whole long trail of relationships you can trace back to that Columbia classroom.
His impact extended beyond academia into the business world. Tweedy Brown, originally a brokerage dealing in illiquid securities, became one of Graham&#8217;s primary brokers.
&nbsp;In fact, one of Warren Buffett&#8217;s first jobs out of college was shuttling stock certificates and checks between Tweedy Brown and Graham&#8217;s office.
The firm&#8217;s principals, watching Graham make substantial money holding securities they merely traded, eventually transitioned into asset management and now operate a significant global value investing firm in Connecticut.
Similarly, Charles Brandes, a Merrill Lynch broker in La Jolla, formed a relationship with the retired Graham when the professor walked in to open an account. They hit it off, and Brandes subsequently established his own successful global value firm implementing Graham&#8217;s teachings.
Graham&#8217;s own private partnership reportedly compounded at approximately 20% annually for over twenty years.
The man practiced what he preached, and he was very good at it.
Graham&#8217;s investment philosophy was distinctly bottom-up, focusing on individual security selection rather than market timing or economic forecasting. He didn&#8217;t care what the market did. He didn&#8217;t pay much attention to what the economy was doing. He looked for undervalued securities with substantial margins of safety and built a portfolio of those.
In his final interview before his death in the mid-1970s, Graham expressed a shift toward simplification, stating that he no longer believed in the intensive analysis methods of earlier decades. Instead, he advocated for his two formulas: the net current asset approach and the simple criteria of undervalued, low-debt, profitable, dividend-paying stocks, a methodology that consistently outperforms the market.
It is the second approach that lies at the heart of the Perfect Portfolio.
Notably, though Graham never intended to be a macro investor, his approach inadvertently produced exceptional macro-timing results. At the Perfect Stock Portfolio, while we analyze macroeconomic reports (and yes, we do read thick stacks of them), our stock selection remains independent of these factors. Nevertheless, our focus on undervalued, profitable companies with strong balance sheets naturally leads to advantageous macro positioning.
The Perfect Stock Portfolio&#8217;s Historical Performance
The effectiveness of this approach is demonstrated by the Perfect Stock Portfolio&#8217;s historical performance during market dislocations:
<ul class="wp-block-list">
<li>2001 Internet Collapse: While the broader market declined 10%, the Portfolio gained 25% by positioning in out-of-favor sectors like steel, furniture, textiles, clothing, metals, and basic industries. We weren&#8217;t buying internet stocks or anything popular, just solid, deeply undervalued companies.</li>
<li>2006-2009 Financial Crisis: By mid-2006, the screen identified only half the usual number of qualifying stocks globally, naturally reducing exposure before the 2008 collapse.</li>
<li>In 2009, the strategy directed investors toward small banks, Japanese stocks, energy, and miners, doubling the market&#8217;s return with gains exceeding 50%.</li>
<li>2016 Election Turmoil:</li>
<li>The Portfolio outperformed by concentrating in Japanese and Chinese equities, small banks, and precious metals miners, avoiding the mess going on in U.S. markets.</li>
<li>COVID-19 Pandemic: In early 2019, the screen again showed significantly fewer qualifying stocks, reducing exposure before the pandemic shock.</li>
<li>As markets bottomed in March 2020, the strategy identified opportunities in small banks, gold stocks, industrial companies, energy at historically low prices (remember that wonderful moment when oil hit zero?), electronics firms, and insurance companies, particularly those with substantial dividends.</li>
<li>The emphasis on safe and cheap contributed to returns that absolutely crushed the broader market recovery.</li>
<li>2022 Downturn: By late 2021, appreciated stocks trading above book value were being sold, and few new qualifying investments could be found. This naturally positioned investors with approximately 50% cash before the 2022 market decline, providing both protection and dry powder for new opportunities.</li>
</ul>
The current iteration of the Perfect Stock Portfolio was initiated in late 2024 amid expectations of a Trump victory and anticipation of pro-business, pro-banking, and pro-market policies similar to 2017. Everyone expected the administration to take the daily performance of the stock market very seriously and respond to it.
That, of course, is not what we got.
However, the Perfect Stock Formula had already directed us away from U.S. equities, with very few domestic stocks qualifying for inclusion. Instead, the portfolio established substantial positions in Europe, China, and Japan. This positioning has proven remarkably effective (to say that&#8217;s an understatement would itself be an understatement) as European markets have reached new highs while U.S. markets have struggled.
&nbsp;Consequently, the portfolio has achieved double-digit returns during a period when U.S. indices have barely maintained flat performance.
The current portfolio maintains its international focus with investments across Canada, Europe, Japan, Germany, China, Denmark, and selective U.S. positions. Sector diversification includes shipping, automotive, printing, gold mining, aerospace and defense, banking, natural gas, electrical generation, insurance, and Latin American exposure through Argentina.
This global positioning is particularly appropriate given the current U.S. market conditions: severe overvaluation, a hesitant Federal Reserve, potential stagflation in the latter half of 2025, and ongoing uncertainty regarding tariffs and trade policy. These factors create an unfavorable backdrop for domestic equities, reinforcing our emphasis on European, Asian, and Latin American markets.
The case for European equities is compelling:
<ul class="wp-block-list">
<li>Valuation Advantage: European equities trade at approximately 14x earnings versus 25x+ for U.S. stocks—a multi-decade valuation gap that shows no signs of closing.</li>
<li>Improving Economic Outlook: Investor confidence is strengthening across Europe, bolstered by expectations of additional interest rate cuts and stimulus from both the European Central Bank and the German government.</li>
<li>Consumer Tailwinds: Falling oil prices are benefiting European consumers, enhancing spending capacity and growth prospects.</li>
<li>Positive Yield Curve: The steepening yield curve across Europe represents a significant positive indicator for banking sector profitability and broader economic activity.</li>
<li>Fiscal Support: Supportive fiscal policies and increased infrastructure spending create a favorable backdrop for growth.</li>
<li>Defense Spending Surge: European defense policy is undergoing a fundamental shift from reliance on U.S. support to self-sufficiency. For the first time since World War II, Europe feels they&#8217;re in it by themselves. The defense policy that&#8217;s been based on &#8220;hang on until the U.S. gets here&#8221; is now becoming &#8220;we&#8217;ve got to do it ourselves.&#8221; This is driving substantial increases in defense-related expenditure with ripple effects throughout associated industries and infrastructure.</li>
</ul>
These factors have generated increasingly positive sentiment among investors and asset allocators, who are redirecting capital from U.S. markets to European opportunities. European institutions that had previously invested in U.S. markets are repatriating capital to domestic industries with enhanced growth prospects.
Japan represents another significant area of opportunity:
<ul class="wp-block-list">
<li>Attractive Valuations: Despite positive fundamentals, Japanese equities remain attractively priced.</li>
<li>Economic Strength: Robust wage growth, solid economic expansion, and recovering tourism contribute to a positive economic environment.</li>
<li>Monetary Policy: The Bank of Japan maintains accommodative policies even as it gradually raises rates in response to price increases—the first meaningful inflation in Japan after decades of stagnation.</li>
<li>AI Adoption Advantage: Japan appears to be outpacing the U.S. in artificial intelligence implementation, driving labor productivity and manufacturing activity.</li>
<li>Financial Stability: High household savings rates provide resilience against external shocks and geopolitical instability. Remember, the average Japanese household has a lot more money in the bank than the average American household, which insulates their economy in ways ours lacks.</li>
<li>Corporate Governance Revolution: Perhaps most significantly, Japan is undergoing unprecedented corporate reforms focused on shareholder value. The government is driving corporate governance improvements, addressing the longstanding issue of companies trading far below book value due to traditional cross-shareholdings and resistance to outside influence.</li>
</ul>
These cross-shareholding structures are being unwound as entrenched management comes under increased pressure. Insurance companies are divesting equity positions in favor of dividends and buybacks. Japanese corporations are demonstrating unprecedented focus on shareholder returns through increased dividends and share repurchases.
International activists and private equity firms are making significant inroads into Japanese markets for the first time in decades. I&#8217;ve been in this business for thirty years, and I&#8217;ve never seen anything like it. KKR is having a lot of success there, Blackstone&#8217;s doing some deals, and we&#8217;re even seeing Elliott Management scoring victories in Japan as they push companies to unlock shareholder value.
This corporate reform movement is facilitating access to deeply undervalued businesses paying dividends while trading below book value, precisely the types of investments that will benefit from ongoing corporate governance improvements.
The Perfect Stock Portfolio currently maintains the following metrics:
<ul class="wp-block-list">
<li>Valuation: Trading at approximately 79% of book value</li>
<li>Dividend Yield:  above 3.5%</li>
<li>Profitability: All portfolio companies are profitable</li>
</ul>
Amazingly, despite impressive performance with some holdings up 80-90% since inception—only one position currently trades above tangible book value: Magellan Aerospace.
Despite a 45% appreciation, we are maintaining this position due to its aerospace and defense exposure. They&#8217;ve gone parabolic and they will be a massive beneficiary of the increased defense spending across Europe.
Other notable positions include:
<ul class="wp-block-list">
<li>China Yuchai International (CYD): Despite a 90% appreciation, still trades at only 65% of tangible book value</li>
<li>Commerce Bank: Up 75% but still trading at just under 90% of tangible book value</li>
</ul>
These examples illustrate that despite strong performance, our holdings remain significantly undervalued at current prices, justifying their continued inclusion in the portfolio.
Recent additions include a coal stock and a dividend-paying Japanese printing company. We maintain a watchlist of potential additions but are exercising patience in the current environment of broad market enthusiasm.
That&#8217;s generally not the atmosphere where we want to come rushing in to add money.
&nbsp;When we get pullbacks, we do have a list of other stocks we want to add to the Perfect Portfolio.
Conclusion: Positioned for Continued Outperformance
Graham&#8217;s principles and investment rules have positioned the Perfect Stock Portfolio advantageously for the current market environment. The strategy enables investors to not only ride out global turmoil but to profit as everything else sort of falls around everybody&#8217;s ears here in the United States.
We&#8217;re avoiding volatility while maintaining substantial profit potential.
I do expect to see a lot of takeover activity within our portfolio companies before all is said and done.
The portfolio is well-situated for the remainder of 2025, having already delivered double-digit returns while U.S. markets have struggled to maintain flat performance.
Our approach, buying quality companies at discounted valuations and holding them, continues to prove effective, as it has consistently done for a century.
It&#8217;s just common sense: buy and hold quality companies purchased at discounted valuations and cash dividend checks along the way
This systematic application of Graham&#8217;s value philosophy not only provides superior returns but also acts as an inadvertent macro timing mechanism—positioning investors defensively before market corrections and aggressively during recoveries, all without attempting to predict economic cycles or market movements.
Graham&#8217;s legacy endures not only in investment theory but in practical application, generating real outperformance across diverse market conditions through a disciplined focus on fundamental value, quality, and safety margins.
The Perfect Stock Portfolio stands as testament to the enduring effectiveness of these principles and they&#8217;re working now just as they have worked for the last one hundred years.

Opinion

The Perfect Stocks Portfolio: May 2025 Update

Biotech

Events

General

GLPG

Galapagos Announces New Data From ATALANTA-1 Study Of Investigational CAR-T Candidate GLPG5101

LightPath Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPTH#NASDAQ">LPTH</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that LightPath Technologies will report an earnings per share (EPS) of $-0.05. 
The market awaits LightPath Technologies's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
<h3>Overview of Past Earnings</h3>
The company's EPS missed by $0.03 in the last quarter, leading to a 7.37% drop in the share price on the following day.
Here's a look at LightPath Technologies's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2025</th>
<th>Q1 2025</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.04</td>
<td>-0.05</td>
<td>-0.05</td>
<td>-0.04</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.07</td>
<td>-0.04</td>
<td>-0.06</td>
<td>-0.07</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-7.000000000000001%</td>
<td>-1.0%</td>
<td>-1.0%</td>
<td>8.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747253102_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of LightPath Technologies were trading at $2.72 as of May 13. Over the last 52-week period, shares are up 93.38%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analysts' Take on LightPath Technologies</h3>
Understanding market sentiments and expectations within the industry is crucial for investors. This analysis delves into the latest insights on LightPath Technologies.
LightPath Technologies has received a total of 2 ratings from analysts, with the consensus rating as Buy. With an average one-year price target of $5.0, the consensus suggests a potential 83.82% upside.
<h3>Comparing Ratings Among Industry Peers</h3>
This comparison focuses on the analyst ratings and average 1-year price targets of Identiv and SmartRent, three major players in the industry, shedding light on their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Buy trajectory for Identiv, with an average 1-year price target of $5.5, suggesting a potential 102.21% upside.</li>
<li>Analysts currently favor an Neutral trajectory for SmartRent, with an average 1-year price target of $1.45, suggesting a potential 46.69% downside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary outlines pivotal metrics for Identiv and SmartRent, demonstrating their respective standings within the industry and offering valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>LightPath Technologies</td>
<td>Buy</td>
<td>1.49%</td>
<td>$1.93M</td>
<td>-9.30%</td>
</tr>
<tr>
<td>Identiv</td>
<td>Buy</td>
<td>-20.86%</td>
<td>$132K</td>
<td>-3.28%</td>
</tr>
<tr>
<td>SmartRent</td>
<td>Neutral</td>
<td>-18.11%</td>
<td>$13.56M</td>
<td>-14.88%</td>
</tr>
</tbody>
</table>

Key Takeaway:
LightPath Technologies ranks highest in Revenue Growth among its peers. It has the highest Gross Profit margin. However, it has the lowest Return on Equity.
<h3>Discovering LightPath Technologies: A Closer Look</h3>
LightPath Technologies Inc is a manufacturer, distributor, and integrator of proprietary optical components and assemblies. It is also engaged in the research and development for optical solutions for the traditional optics markets and communications markets. The company's business based on the following product groups: precision molded optics, specialty products, and infrared products. It currently serves the following major markets, distribution and catalog, laser, industrial, instrumentation, telecommunications, and defense.
<h3>LightPath Technologies: Delving into Financials</h3>
Market Capitalization Analysis: Falling below industry benchmarks, the company's market capitalization reflects a reduced size compared to peers. This positioning may be influenced by factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining LightPath Technologies's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.49% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.
Net Margin: LightPath Technologies's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive -35.18% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): LightPath Technologies's ROE excels beyond industry benchmarks, reaching -9.3%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): LightPath Technologies's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of -5.54%, the company showcases efficient use of assets and strong financial health.
Debt Management: With a below-average debt-to-equity ratio of 0.47, LightPath Technologies adopts a prudent financial strategy, indicating a balanced approach to debt management.
<a href="https://www.benzinga.com/quote/LPTH/earnings">To track all earnings releases for LightPath Technologies visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

LPTH

Preview: LightPath Technologies's Earnings

scPharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SCPH#NASDAQ">SCPH</a>) reported quarterly losses of $(0.37) per share which missed the analyst consensus estimate of $(0.30) by 23.33 percent. This is a 2.78 percent decrease over losses of $(0.36) per share from the same period last year. The company reported quarterly sales of $11.75 million which beat the analyst consensus estimate of $11.63 million by 1.06 percent. This is a 92.59 percent increase over sales of $6.10 million the same period last year.

SCPH

scPharmaceuticals Q1 EPS $(0.37) Misses $(0.30) Estimate, Sales $11.75M Beat $11.63M Estimate

Shares of Capital One Financial Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COF#NYSE">COF</a>) slid on Wednesday as New York Attorney General Letitia James launched a sweeping lawsuit accusing the banking giant of a deceptive, multi-year scheme that denied long-time customers millions in interest by secretly freezing rates on older savings accounts while offering higher <a href="https://www.benzinga.com/topic/regulations">yields to new ones.</a>
<h3 class="wp-block-heading">What Did Capital One Allegedly Do?</h3>
According to the complaint filed in the Southern District of New York, Capital One maintained a misleading "two-tier" savings account system that disadvantaged legacy customers. 
The bank's original "360 Savings" accounts were marketed as high-interest offerings, with slogans like "Your money will earn much more than what it would in an average savings or money market account…What's the catch? There is none."
Yet, in September 2019, Capital One quietly introduced a nearly identical account called "360 Performance Savings" with dramatically higher rates—1.90% versus 1.00% at launch, and eventually up to 4.35% while 360 Savings customers were stuck at 0.30%.
<h3 class="wp-block-heading">Massive Gap In Returns Over Time</h3>
As a result, customers believed they still held the advertised "high-interest" product, unaware of the performance gap. For instance, $10,000 in a 360 Savings account earned just $186 in five years. In a 360 Performance Savings account, it would have earned $1,090 — a nearly sixfold difference.
<h3 class="wp-block-heading">What's At Stake For Capital One?</h3>
Capital One had $318 billion in consumer banking deposits as of December 2024. Customer trust, a key driver for retail deposits, could be at risk. 
While the company has not yet responded publicly, the lawsuit is already moving markets — Capital One's shares fell 1.9% on Wednesday, the day of the announcement.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45414023/magnificent-seven-add-36-trillion-since-april-lows-is-this-rally-just-beginning">Magnificent Seven Add $3.6 Trillion Since April Lows: Is This Rally Just Beginning? </a></li>
</ul>
Photo: Shutterstock

Government

Large Cap

Regulations

Capital One Sued By New York Over Hidden Interest Rate Scheme That Cost Consumers Millions

eGain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EGAN#NASDAQ">EGAN</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.04 by 25 percent. This is a 62.5 percent decrease over earnings of $0.08 per share from the same period last year. The company reported quarterly sales of $21.00 million which missed the analyst consensus estimate of $21.24 million by 1.14 percent. This is a 6.04 percent decrease over sales of $22.35 million the same period last year.

eGain Q3 Adj. EPS $0.03 Misses $0.04 Estimate, Sales $21.00M Miss $21.24M Estimate

CaliberCos (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CWD#NASDAQ">CWD</a>) is preparing to release its quarterly earnings on Thursday, 2025-05-15. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect CaliberCos to report an earnings per share (EPS) of $-0.02.
Anticipation surrounds CaliberCos's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Past Earnings Performance</h3>
During the last quarter, the company reported an EPS missed by $0.47, leading to a 2.46% drop in the share price on the subsequent day.
Here's a look at CaliberCos's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
<th>Q4 2023</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>-0.04</td>
<td>-0.13</td>
<td>-0.11</td>
<td></td>
<td>-0.17</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.51</td>
<td>0.01</td>
<td>-0.22</td>
<td>-0.18</td>
<td>-0.11</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-2.0%</td>
<td>-1.0%</td>
<td>3.0%</td>
<td>-7.000000000000001%</td>
<td>0.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1747253049_0.png" alt="eps graph" />
<h3>Performance of CaliberCos Shares</h3>
Shares of CaliberCos were trading at $4.15 as of May 13. Over the last 52-week period, shares are down 76.71%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release. 
<a href="https://www.benzinga.com/quote/CWD/earnings">To track all earnings releases for CaliberCos visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

A Preview Of CaliberCos's Earnings

BiomX (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PHGE#AMEX">PHGE</a>) is set to give its latest quarterly earnings report on Thursday, 2025-05-15. Here's what investors need to know before the announcement.
Analysts estimate that BiomX will report an earnings per share (EPS) of $-0.30. 
The announcement from BiomX is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.
It's worth noting for new investors that guidance can be a key determinant of stock price movements.
Here's a look at BiomX's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td></td>
<td></td>
<td></td>
<td></td>
</tr>
<tr>
<td>EPS Actual</td>
<td>-0.91</td>
<td>-0.31</td>
<td>-0.7</td>
<td>-2.8</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-11.0%</td>
<td>-17.0%</td>
<td>-12.0%</td>
<td>7.000000000000001%</td>
</tr>
</tbody>
</table>

<h3>Stock Performance</h3>
Shares of BiomX were trading at $0.535 as of May 13. Over the last 52-week period, shares are down 83.44%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/PHGE/earnings">To track all earnings releases for BiomX visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

PHGE

A Look at BiomX's Upcoming Earnings Report

Press Releases

Ingram Micro Holding Corporation (INGM) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Securities Fraud Investigation Into Ingram Micro Holding Corporation (INGM) Announced – Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm

Legal

Kirby McInerney LLP Announces Investigation Against Ingram Micro Holding Corporation (INGM) on Behalf of Investors

Ingram Micro's Xvantage Integrations Hub Delivers a Plug-and-Play Experience, Virtually Eliminating the Complexity of Software Integrations

INGRAM ALERT: Bragar Eagel & Squire, P.C. is Investigating Ingram Micro Holding Corporation on Behalf of Ingram Stockholders and Encourages Investors to Contact the Firm

Comments

Ingram Micro Holding

空売り

Ingram Micro Holding (NYSE:INGM) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル